Heart Rate Variability Biofeedback for Smoking Cessation

• Status: Completed
• Trial end date: 2020-02-20
• Target enrollment: 0
• Participant gender: All

Summary

Open trial of heart rate variability biofeedback as an adjunct to individualized smoking cessation counseling (SCT) plus transdermal nicotine replacement patch (NRT) in smokers with elevated emotional distress.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Rutgers, The State University of New Jersey
• Collaborator: National Institute on Drug Abuse (NIDA)
• Treatments: Nicotine

Criteria

Inclusion Criteria:

• Smoking ≥5 cigarettes, daily, for at least two years

• expired carbon monoxide analysis of breath sample ≥8 ppm

• elevated affective distress

• motivation to quit

• computer proficient

Exclusion Criteria:

• current use of other tobacco or nicotine products for recreation or to aid in cessation, use of pharmacological intervention for cessation, or current enrollment in a psychosocial intervention for smoking cessation

• endorsement of current or past psychotic or manic symptoms indicative of bipolar spectrum or schizophrenia spectrum disorders and/or current suicidal or homicidal ideation

• inability to provide written informed consent

• current evidence of another substance use disorder

• severe visual or hearing impairments

• self-reported medical condition or medication use that may be contraindicated for participation in a HRVB or confound autonomic parameters:

• self-reported medical issues of potential concern to nicotine patch users